High-Content Assay to Study Protein Prenylation

This publication has 37 references indexed in Scilit:

• Anti-Cancer Therapy: Targeting the Mevalonate Pathway
  Current Cancer Drug Targets, 2006
• Safety of Intravenous and Oral Bisphosphonates and Compliance With Dosing Regimens
  The Oncologist, 2004
• Protein prenylation: a pivotal posttranslational process
  Biochemical and Biophysical Research Communications, 2003
• Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells
  Cellular and Molecular Life Sciences, 2001
• Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics
  Biochemical Pharmacology, 2000
• Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase
  Archives of Biochemistry and Biophysics, 2000
• Mechanism of Aminobisphosphonate Action: Characterization of Alendronate Inhibition of the Isoprenoid Pathway
  Biochemical and Biophysical Research Communications, 1999
• Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing Bisphosphonates
  Biochemical and Biophysical Research Communications, 1999
• Binding and antiresorptive properties of heterocycle-containing bisphosphonate analogs: structure-activity relationships
  Bone, 1998
• Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.
  Proceedings of the National Academy of Sciences, 1982